Pavan Asalapuram

Pavan Asalapuram

Research Assistant

Global health researcher and translational scientist advancing diagnostics, AMR surveillance, One Health implementation, and scalable policy solutions for infectious diseases.

Visiting address: Widerströmska huset Tomtebodavägen 18 A, plan 3, 17165 Solna
Postal address: K9 Global folkhälsa, K9 GPH Stålsby Lundborg, 171 77 Stockholm

About me

  • I am a researcher in global health with a translational background in infectious-disease diagnostics and a growing focus on One Health AMR systems, implementation, and policy.

    My work in the Health Systems and Policy group, led by Professor Cecilia Stålsby Lundborg, lies at the intersection of translational diagnostics, AMR surveillance, implementation, and health policy within a One Health framework. My research examines how diagnostic technologies, disease-burden evidence, antimicrobial use and resistance data, surveillance systems, health-economic considerations, and governance structures can be better connected across human, animal, and environmental health. The aim is to translate scientific evidence into operational and equitable tools for One Health public-health decision-making.

    I have more than two decades of experience in infectious diseases, molecular diagnostics, bench-to-market product development, and the clinical evaluation of diagnostic technologies across Europe, Asia, and Africa. I contributed to the development of a drug-resistant tuberculosis diagnostic platform included in the Treatment Action Group’s 2024 TB Diagnostics Pipeline and referenced in the WHO Global Tuberculosis Report 2024. This work has been supported by the Bill & Melinda Gates Foundation, the European Innovation Council, European research programmes, and Indian research funding initiatives.

    My long-term goal is to develop integrated diagnostic and surveillance approaches that enable earlier detection of antimicrobial resistance, more appropriate treatment, and evidence-informed public-health action within a One Health framework.

Research

  • My current research focuses on rapid multiplex molecular diagnostics for antimicrobial resistance, diagnostic-to-surveillance data systems, One Health implementation frameworks, and AI-enabled approaches to risk detection and early decision support.

    A central question guiding my work is: How can evidence on disease burden and diagnostic innovation be translated into integrated and actionable One Health surveillance systems?

    I welcome collaboration in antimicrobial resistance, One Health, infectious-disease diagnostics, implementation science, surveillance, health policy, and health-system strengthening.

Teaching

  • My teaching interests include global health, infectious diseases, antimicrobial resistance, One Health, diagnostics, implementation science, and health innovation.

    I have supervised approximately 20 Bachelor’s and Master’s students and research projects, taught laboratory courses at undergraduate and postgraduate levels, and delivered capacity-strengthening workshops for researchers, clinicians, and policymakers.

Articles

All other publications

  • Published conference paper: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2026;S8(Special Issue 2026 – Abstracts):S8
    Pavan A; Nikhil S; Vasim A; Narayanan M; Stålsby Lundborg C
  • Patent: 2025
    Portable and adaptive modular sterilization and lubrication system and applications
    Asalapuram P
  • Patent: 2025
    One-Step Intercepting polymerase chain reaction (IntPCR) for simultaneous detection of wildtypes and selective point mutations and applications thereof
    Asalapuram P; Nikhil S
  • Patent: 2025
    Analytical, clinical and interdisciplinary applications utilizing Shigella flexneri apyrase
    Asalapuram P
  • Patent: 2024
    Novel coating and immobilization buffer for antigens and antibodies and uses thereof
    Asalapuram P; Nikhil S; Krishnan S
  • Patent: 2022
    Modified Shigella apyrase and uses thereof
    Asalapuram P; Nikhil S
  • Patent: 2017
    Diagnostic device and related method
    Asalapuram P; Mats NB
  • Patent: 2016
    Analytical and diagnostic methods utilizing Shigella flexneri apyrase
    Asalapuram P; Aman R
  • Patent: 2009
    A method to detect the microbial resistance to antibiotics using fluorescence
    Asalapuram P; Krishnan S; Alagumaruthanayagam A
  • Review: FOOD TECHNOLOGY AND BIOTECHNOLOGY. 2008;46(2):125-145
    The Need and New Tools for Surveillance of Escherichia coli Pathogens
    Asalapuram P; Krishnan Sankaran
  • Report: 2005;:26
    Characterization of diarrhoeagenic E. coli (EPEC and EHEC) from incidences of infantile diarrhoea
    Asalapuram P

Grants

  • Exploring mlfoDx MDR-TB diagnostic platform in Africa and Latin American markets
    Business Sweden
    1 November 2023
  • Rapid Affordable Reliable-ELISA (RAR-ELISA) platform for the diagnosis of important helminthic infections
    Department of Biotechnology , Ministry of Science and Technology
    1 June 2023 - 31 December 2024
  • Multiplex Diagnostic Platform for Accurate and Rapid Detection of MDR & pre-XDR-TB
    IPE Global
    1 January 2023
  • Adaptable multi-flow diagnostics for multidrug-resistant TB using tongue swabs
    Bill and Melinda Gates Foundation
    1 November 2022
  • AdvanceTB: Towards an improvement in diagnostics and treatment strategies for tuberculosis control
    1 September 2022 - 30 September 2026
    The ADVANCE-TB is a research network that offers opportunities for collaboration between clinicians, academic researchers from interdisciplinary backgrounds, industry and non-governmental organizations to achieve breakthroughs difficult to obtain by individual partners, allowing a better understanding of the underlying host-pathogen mechanisms, enabling the transfer of basic science into innovative applications and allowing product development and clinical validation.
  • mfloDx: An Adaptable Multiflow Diagnostic Platform to Genetically Identify Drug Resistant Infection
    European Commission Directorate-General for Research and Innovation
    1 January 2020 - 30 June 2024
  • mfloDx: An Adaptable Multiflow Diagnostic Platform to Genetically Identify Drug Resistant Infection
    European Commission Directorate-General for Research and Innovation
    1 October 2019 - 29 February 2020
  • RCA-ADT diagnostic platform for the rapid detection of enteric pathogens
    EPSRC grant
    1 January 2016 - 31 December 2017
  • A multiplex diagnostic test for multi-drug/extensively drug-resistant tuberculosis
    VINNOVA
    1 November 2013 - 30 September 2016
  • INNOVA4TB: Innovative development to enable individualised tuberculosis treatment
    European Commission Directorate-General for Research and Innovation
  • Integrated fluidic-array-microsystem for rapid screening of extended spectrum β-lactamases and multidrug resistant pathogens.
    KTH - Life Science Platform
  • Real-time wireless biosensor networks for the surveillance of microbes and pollutants in drinking water supply lines
    KTK Life Science Technology Platform

Employments

  • Affiliated to Research, Department of Global Public Health, Karolinska Institutet, 2022-
  • Research Assistant, Department of Global Public Health, Karolinska Institutet, 2026-2027
  • CEO, Mitti Lifetek AB, 2019-2024
  • Founder & CEO, EMPE Diagnostics AB, 2016-2024
  • Postdoctor, Stockholm University, 2013-2016
  • Researcher, Biothema AB & KTH, 2012-2013
  • Postdoctor, Molecular Diagnostics, Royal Institute of Technology, 2010-2011

Degrees and Education

  • PhD, Clinical Biotechnology, Anna University, Chennai, 2010
  • M.S. (res), Clinical Biotechnology, Anna University, Chennai, 2006
  • EPGD in Hospital & Health Care Management, Loyola Institute of Business Administration (LIBA), 2002
  • B. Pharmacy, Pharmacy, Madras Medical College, Dr MGR Medical University, 2001

News from KI

Events from KI